Researchers have found that a commonly used drug to treat anemia in heart failure patients — darbepoetin alfa — does not improve patients’ health, nor does it reduce their risk of death from heart failure.
Researchers have found that a commonly used drug to treat anemia in heart failure patients — darbepoetin alfa — does not improve patients’ health, nor does it reduce their risk of death from heart failure.